These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 28919446)
1. Increased interferon-mediated immunity following in vitro and in vivo Modafinil treatment on peripheral immune cells. Zager A; Brandão WN; Margatho RO; Cruz DSG; Peron JP; Tufik S; Andersen ML; Moresco M; Pizza F; Plazzi G; Kornum BR; Palermo-Neto J Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():297-305. PubMed ID: 28919446 [TBL] [Abstract][Full Text] [Related]
2. The wake-promoting drug Modafinil prevents motor impairment in sickness behavior induced by LPS in mice: Role for dopaminergic D1 receptor. Zager A; Brandão WN; Margatho RO; Peron JP; Tufik S; Andersen ML; Kornum BR; Palermo-Neto J Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():468-476. PubMed ID: 28499899 [TBL] [Abstract][Full Text] [Related]
3. Effects of modafinil on nocturnal sleep patterns in patients with narcolepsy: A cohort study. Chin WC; Huang YS; Trevor Lam NY; Mak KY; Tang I; Wang CH; Lin C Sleep Med; 2024 Jul; 119():95-102. PubMed ID: 38669836 [TBL] [Abstract][Full Text] [Related]
4. Disharmony between wake- and respiration-promoting activities: effects of modafinil on ventilatory control in rodents. Terada J; Fukushi I; Takeda K; Hasebe Y; Pokorski M; Tatsumi K; Okada Y Respir Res; 2016 Nov; 17(1):148. PubMed ID: 27842553 [TBL] [Abstract][Full Text] [Related]
5. Modulating the immune response with the wake-promoting drug modafinil: A potential therapeutic approach for inflammatory disorders. Zager A Brain Behav Immun; 2020 Aug; 88():878-886. PubMed ID: 32311496 [TBL] [Abstract][Full Text] [Related]
6. Wake-promoting effects of ONO-4127Na, a prostaglandin DP1 receptor antagonist, in hypocretin/orexin deficient narcoleptic mice. Sagawa Y; Sato M; Sakai N; Chikahisa S; Chiba S; Maruyama T; Yamamoto J; Nishino S Neuropharmacology; 2016 Nov; 110(Pt A):268-276. PubMed ID: 27474349 [TBL] [Abstract][Full Text] [Related]
7. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. US Modafinil in Narcolepsy Multicenter Study Group. Ann Neurol; 1998 Jan; 43(1):88-97. PubMed ID: 9450772 [TBL] [Abstract][Full Text] [Related]
8. Dopaminergic-adrenergic interactions in the wake promoting mechanism of modafinil. Wisor JP; Eriksson KS Neuroscience; 2005; 132(4):1027-34. PubMed ID: 15857707 [TBL] [Abstract][Full Text] [Related]
9. An Overview of the Clinical Uses, Pharmacology, and Safety of Modafinil. Murillo-Rodríguez E; Barciela Veras A; Barbosa Rocha N; Budde H; Machado S ACS Chem Neurosci; 2018 Feb; 9(2):151-158. PubMed ID: 29115823 [TBL] [Abstract][Full Text] [Related]
10. A need for new treatments in narcolepsy. Strambi LF Lancet Neurol; 2013 Nov; 12(11):1039-40. PubMed ID: 24107291 [No Abstract] [Full Text] [Related]
11. Modafinil Reduces Parasympathetic Activity but Does Not Influence Autonomic Reactivity to Orthostatic Load in Narcolepsy Type 1. Bušek P; Bušková J; Miletínová E; Mladá K; Nevšímalová S; Šonka K Clin Neuropharmacol; 2018; 41(4):111-115. PubMed ID: 29901476 [TBL] [Abstract][Full Text] [Related]
12. Impact of Astroglial Connexins on Modafinil Pharmacological Properties. Duchêne A; Perier M; Zhao Y; Liu X; Thomasson J; Chauveau F; Piérard C; Lagarde D; Picoli C; Jeanson T; Mouthon F; Dauvilliers Y; Giaume C; Lin JS; Charvériat M Sleep; 2016 Jun; 39(6):1283-92. PubMed ID: 27091533 [TBL] [Abstract][Full Text] [Related]
13. Findings of the Maintenance of Wakefulness Test and its relationship with response to modafinil therapy for residual excessive daytime sleepiness in obstructive sleep apnea patients adequately treated with nasal continuous positive airway pressure. Inoue Y; Miki M; Tabata T Sleep Med; 2016; 27-28():45-48. PubMed ID: 27938918 [TBL] [Abstract][Full Text] [Related]
14. Prader-Willi syndrome, excessive daytime sleepiness, and narcoleptic symptoms: a case report. Weselake SV; Foulds JL; Couch R; Witmans MB; Rubin D; Haqq AM J Med Case Rep; 2014 Apr; 8():127. PubMed ID: 24742112 [TBL] [Abstract][Full Text] [Related]
15. Differential effects of modafinil on memory in naïve and memory-impaired rats. Garcia VA; Souza de Freitas B; Busato SB; D'avila Portal BC; Piazza FC; Schröder N Neuropharmacology; 2013 Dec; 75():304-11. PubMed ID: 23958446 [TBL] [Abstract][Full Text] [Related]
17. Initiating treatment with modafinil for control of excessive daytime sleepiness in patients switching from methylphenidate: an open-label safety study assessing three strategies. Thorpy MJ; Schwartz JR; Kovacevic-Ristanovic R; Hayduk R Psychopharmacology (Berl); 2003 Jun; 167(4):380-5. PubMed ID: 12709775 [TBL] [Abstract][Full Text] [Related]
18. Comparative effects of modafinil and amphetamine on daytime sleepiness and cataplexy of narcoleptic dogs. Shelton J; Nishino S; Vaught J; Dement WC; Mignot E Sleep; 1995 Dec; 18(10):817-26. PubMed ID: 8746387 [TBL] [Abstract][Full Text] [Related]
19. Modafinil more effectively induces wakefulness in orexin-null mice than in wild-type littermates. Willie JT; Renthal W; Chemelli RM; Miller MS; Scammell TE; Yanagisawa M; Sinton CM Neuroscience; 2005; 130(4):983-95. PubMed ID: 15652995 [TBL] [Abstract][Full Text] [Related]
20. Effect of modafinil on fatigue, mood, and health-related quality of life in patients with narcolepsy. Becker PM; Schwartz JR; Feldman NT; Hughes RJ Psychopharmacology (Berl); 2004 Jan; 171(2):133-9. PubMed ID: 14647965 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]